Genocea Biosciences (GNCA) Financials

$0.00

$0.00 (-33.33%)

As on 24-Feb-2023 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	1.91	1.64	1.36	--	--	--
Cost of Revenue	--	--	--	26.95	25.21	39.20
Gross Profit	--	--	0.00	-26.95	-25.21	-39.20
Operating Expenses	57.36	53.73	48.35	38.99	39.52	52.64
Operating Profit (EBIT)	-55.44	-52.09	-46.99	-38.99	-39.52	-55.26
Other Income	10.52	--	4.66	0.99	12.73	0.25
Profit before Tax	-37.19	-33.20	-43.71	-38.95	-27.81	-56.71
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-37.19	-33.20	-43.71	-38.95	-27.81	-56.71
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-37.19	-33.20	-43.71	-38.95	-27.81	-56.71

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	12.39	27.08	8.98	25.04	7.34	-6.05
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	8.37	10.21	64.52	21.29	13.05	7.76
Current Liabilities	18.03	18.68	25.00	6.28	10.73	15.78
Total Liabilities	56.82	55.97	98.49	52.61	31.12	17.49

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	14.38	14.15	16.27	11.03	4.06	4.41
Current Assets	24.41	41.82	82.23	41.58	27.06	13.08
Total Assets	56.82	55.97	98.49	52.61	31.12	17.49
Total Debt*	15.49	11.13	23.87	14.52	14.82	14.31
Net Current Assets	6.38	27.15	57.23	35.30	16.33	-2.70

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-45.37	-41.65	-37.73	-41.24	-47.60
Cash Flow from Investing Activities	--	-3.21	-2.56	-1.09	-0.13	34.91
Cash from Financing Activities	--	5.96	83.85	52.90	55.46	-2.46
Net Cash Inflow / Outflow	--	--	39.64	14.08	14.09	-15.15

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-93.43	-120.72	-126.21	-182.86	-160.29
ROE (%)	-148.13	-184.13	-256.96	-240.60	-4,328.56	-287.20
ROA (%)	-48.88	-42.98	-57.86	-93.04	-114.44	-129.79
EBIT Margin (%)	-1,910.88	-3,174.47	-3,115.08	--	--	--
Net Margin (%)	-299.25	-2,022.91	-726.87	-3,954.31	-218.50	-22,684.00
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	40.62	0.21	--	--	--	-1.00
EBIT Growth (%)	11.89	-23.05	-11.39	-41.86	51.30	-14.99
Net Profit Growth (%)	13.19	24.06	-12.23	-40.05	50.96	-14.40
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.01	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.13	0.76	1.36	0.69	0.45	-0.04
Close Price ($)	1.25	1.16	2.42	2.07	2.29	9.28
High Price ($)	2.90	4.05	5.75	11.28	10.08	58.32
Low Price ($)	0.85	0.91	1.10	1.99	2.24	8.08
Market Cap ($ Cr)	0.01	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.24	0.41	2.66	0.58	2.02	-2.37
Short term debt to equity ratio	0.57	0.26	1.72	0.04	0.72	-1.10
Current Ratio	1.35	2.24	3.29	6.62	2.52	0.83
Quick Ratio	1.35	--	--	--	--	0.83
Interest Coverage	-12.40	-46.47	-30.68	-40.17	-26.24	-32.26

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.03	0.02	0.02	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	14.99	37.49	30.55
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.